Read the latest press releases for 4D pharma plc.
Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.
7 Oct 2020, 07:00
4D pharma announces topline results from Blautix® Phase II BHT-II-002 trial in IBS-C and IBS-D
23 Sep 2020, 07:00
4D pharma makes strategic appointment of independent Non-Executive Director in response to new…
1 Sep 2020, 10:00
4D pharma's Research Director, Dr Imke Mulder, and members of her Research team provide an overview…
26 Aug 2020, 07:30
4D pharma announces complete 6-month clinical benefit data from Part A of its ongoing trial of Live…
6 Jul 2020, 07:00
4D commences treatment of the first patients in Part B of its Phase I/II clinical trial of MRx0518…
2 Jul 2020, 07:00
Phase II study of MRx-4DP0004 in patients hospitalized with COVID-19 open for enrolment.
Dosing of…
5 Jun 2020, 07:45
4D's Chairman, CEO and CSO provide updates on the company’s clinical programmes in oncology and…
11 May 2020, 07:30
4D pharma plc announces successful completion of Part A of a Phase I/II clinical trial of MRx0518 in…
20 Apr 2020, 07:00
4D announces expedited UK regulatory acceptance to commence Phase II study in COVID-19
17 Apr 2020, 08:00
4D pharma plc today announces the key findings of a planned interim analysis in its BHT-II-0002…
17 Apr 2020, 08:00
4D pharma today announces that Prof. Axel Glasmacher, MD, has been appointed as Non-Executive…
17 Mar 2020, 08:00
4D presents an update on the previously reported interim data from its ongoing Phase I/II study of…
6 Jan 2020, 08:00
4D pharma announces opening of a study investigating MRx0518 in combination with radiotherapy in…
6 Nov 2019, 08:00
4D pharma today announced preliminary safety and clinical observations from an ongoing Phase I/II…
